Zobrazeno 1 - 10
of 1 215
pro vyhledávání: '"Guerini-Rocco E"'
Autor:
Guidi, L., Valenza, C., Battaiotto, E., Trapani, D., Ghioni, M.C., Crimini, E., Boscolo Bielo, L., Venetis, K., Belli, C., Bottiglieri, L., Gervaso, L., Cella, C.A., Ciardiello, D., Spada, F., Benini, L., Adorisio, R., Mane, E., Fazio, N., Guerini Rocco, E., Curigliano, G., Zampino, M.G.
Publikováno v:
In ESMO Open August 2024 9(8)
Autor:
Ivanova M; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Porta FM; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., D'Ercole M; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Pescia C; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Sajjadi E; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy., Cursano G; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., De Camilli E; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Pala O; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Mazzarol G; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Venetis K; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Guerini-Rocco E; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, 20141, Milan, Italy., Viale G; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy., Fusco N; Division of Pathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy. nicola.fusco@ieo.it.; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy. nicola.fusco@ieo.it.
Publikováno v:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Jan; Vol. 484 (1), pp. 3-14. Date of Electronic Publication: 2023 Sep 28.
Autor:
Boscolo Bielo L; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Guerini Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Milan; Division of Pathology, European Institute of Oncology IRCCS, Milan., Trapani D; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Zagami P; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Taurelli Salimbeni B; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan., Esposito A; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan., Belli C; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan., Crimini E; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan., Munzone E; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan; Division of Pathology, European Institute of Oncology IRCCS, Milan., Criscitiello C; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Marra A; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan. Electronic address: antonio.marra@ieo.it., Curigliano G; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan. Electronic address: giuseppe.curigliano@ieo.it.
Publikováno v:
ESMO open [ESMO Open] 2024 Oct 01; Vol. 9 (10), pp. 103731. Date of Electronic Publication: 2024 Oct 01.
Autor:
Guerini-Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Cursano G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Mane E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pepe F; Department of Public Health, Federico II University of Naples, Naples, Italy., Negrelli M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; School of Pathology, University of Milan, Milan, Italy., Olmeda E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; School of Pathology, University of Milan, Milan, Italy., Vacirca D; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Ranghiero A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Malapelle U; Department of Public Health, Federico II University of Naples, Naples, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: nicola.fusco@ieo.it.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Sep; Vol. 201, pp. 104427. Date of Electronic Publication: 2024 Jun 23.
Autor:
Belli C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy., Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Repetto M; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center, New York 10065, United States., Crimini E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Scalia R; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy., Diana A; Medical Oncology Unit, Ospedale del Mare, Naples 80147, Italy., Orefice J; Medical Oncology Unit, Ospedale del Mare, Naples 80147, Italy., Ascione L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Pellizzari G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy., Daniele B; Medical Oncology Unit, Ospedale del Mare, Naples 80147, Italy., Guerini-Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.
Publikováno v:
The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. 707-715.
Autor:
Sajjadi E; Department of Oncology and Hemato-Oncology, University of Milan.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Department of Oncology and Hemato-Oncology, University of Milan.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Bonizzi G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Vago G; Department of Oncology and Hemato-Oncology, University of Milan., Guerini-Rocco E; Department of Oncology and Hemato-Oncology, University of Milan.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) [Eur J Cancer Prev] 2023 Sep 01; Vol. 32 (5), pp. 460-467. Date of Electronic Publication: 2023 Apr 10.
Autor:
Attili I; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Asnaghi R; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy., Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Adorisio R; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Lombardi M; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Corvaja C; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Fuorivia V; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy., Carnevale Schianca A; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy., Trillo Aliaga P; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Spitaleri G; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Del Signore E; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Guarize J; Division of Interventional Pulmonology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Spaggiari L; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.; Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Guerini-Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., de Marinis F; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2024 Jul 31; Vol. 13 (15). Date of Electronic Publication: 2024 Jul 31.
Autor:
Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Repetto M; Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Crimini E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Belli C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Setola E; Melanoma, Sarcoma and Rare Tumors Oncology Department, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Parma G; Department of Gynecology, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Guerini Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Colombo N; Department of Gynecology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publikováno v:
The oncologist [Oncologist] 2024 Jul 05; Vol. 29 (7), pp. 560-565.
Autor:
Pepe F; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131, Naples, Italy., Guerini-Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy., Fassan M; Department of Medicine (DIMED), Surgical Pathology & Cytopathology Unit, University of Padua, Padova, Italy.; Istituto Oncologico Veneto IRCCS, Padova, Italy., Fusco N; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy., Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy., Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy., Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy., Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy., Taormina SV; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy., Russo G; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131, Naples, Italy., Rebellato E; Department of Medicine (DIMED), Surgical Pathology & Cytopathology Unit, University of Padua, Padova, Italy., Munari G; Istituto Oncologico Veneto IRCCS, Padova, Italy., Moreno-Manuel A; Molecular Oncology Laboratory, Fundación Investigación Hospital General Universitario de Valencia, 46014, Valencia, Spain.; TRIAL Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red Cáncer, CIBERONC, Madrid, Spain., De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Zamagni C; Unit of Oncology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy., Valabrega G; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy., Malapelle U; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131, Naples, Italy umberto.malapelle@unina.it., Troncone G; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131, Naples, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy., Iaccarino A; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131, Naples, Italy.
Publikováno v:
Journal of clinical pathology [J Clin Pathol] 2024 Jun 19; Vol. 77 (7), pp. 478-485. Date of Electronic Publication: 2024 Jun 19.
Autor:
Ivanova M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., D'Ercole M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Porta FM; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Di Venosa B; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Di Bella C; Department of Pathology, IRCCS San Gerardo Hospital, University of Milan-Bicocca, Monza (MB), Italy., Pagni F; Department of Pathology, IRCCS San Gerardo Hospital, University of Milan-Bicocca, Monza (MB), Italy., Guerini-Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
Publikováno v:
Pathologica [Pathologica] 2024 Jun; Vol. 116 (3), pp. 153-157.